6月10日9:30,仁医医疗三人团队前往哥廷根大学医疗中心,拜访病理科主任、哥廷根癌症中心副主任、国际病理学学会德国分会主席Ströbel 教授,并就中德在精准病理诊断领域的合作进行了深入交流。Ströbel教授是德国病理学界的重要人物,曾参与主笔世界卫生组织(WHO)2004、2015与2021年版肿瘤分类标准中有关肺、胸膜、胸腺和心脏肿瘤的病理学和遗传学章节。作为2025年德国病理学年会主席,他将于6月12日至14日在莱比锡主持这一年度学术盛会。哥廷根大学创立于1737年,是德国最古老、学术氛围最浓厚的大学之一,其附属医疗中心是下萨克森州南部唯一被认证的最高等级医疗服务提供者,在德国医学体系中占据核心地位。其病理科每年处理约4.5万个病例,制作评估约20万份组织学样本,诊断流程已全面实现电子化。科研方面设有5个由教授领导的研究团队,涵盖组织病理学、分子病理与人工智能等方向,科研架构系统完善、交叉融合。2020年,Ströbel教授与西门子联合发起“Cancer Scout”人工智能研究项目,获得德国联邦教育与研究部(BMBF)资助,总金额高达960万欧元。该项目致力于开发一种基于AI的“数字活检”工具,利用医生在日常诊断中最常用的常规病理切片图像,预测患者肿瘤是否存在关键的分子突变,从而在无需额外分子检测的情况下,辅助判断病人是否适合靶向治疗。项目构建了一个大型、跨中心的图像-分子数据库,收集成千上万例肺癌、结直肠癌等实体瘤的样本,通过深度学习模型识别图像中极其细微的细胞形态与分子突变之间的潜在关联。这项技术有望在降低诊断成本、提升诊断效率的同时,为德国每年近50万例新发癌症患者提供更便捷、普及的精准医疗方案。Ströbel教授表示,自己早在1993年就曾访问中国武汉,对中国医疗体系的发展始终保持高度兴趣。他即将与深圳知名大学附属医院开启深度合作,同时也非常期待与仁医医疗团队的后续合作,认为这将为他带来一次全新的对中国的理解与体验。
At 9:30 am on June 10, the team of three from Gloryren went to the University Medical Center Göttingen and visited Prof. Ströbel, the Director of the Institute of Pathology, Deputy Spokesperson of the Göttingen Comprehensive Cancer Center (G-CCC), and President of the German Division of the International Academy of Pathology(IAP). They engaged in in-depth discussions regarding Sino-German cooperation in the field of precision pathological diagnosis. Prof. Ströbel is a prominent figure in the field of pathology in Germany. He has co-authored numerous chapters of 2004, 2015, and 2021 editions of the World Health Organization (WHO) Classification of Tumors Volume on “Pathology and Genetics of Tumors of the Lung, Pleura, Thymus, and Heart”. As the President of the Annual Meeting of the German Society of Pathology in 2025, he will preside over this annual academic event in Leipzig from June 12 to 14. Founded in 1737, the University of Göttingen is one of Germany's oldest and most academically renowned institutions. Its affiliated medical center serves as the only certified highest-level healthcare provider in southern Lower Saxony, playing a central role in Germany's medical system. The Institute of Pathology handles approximately 45,000 cases annually, preparing and evaluating around 200,000 histological samples, with fully digitized diagnostic workflows. In research, it has five professor-led teams focusing on histopathology, molecular pathology, and artificial intelligence, featuring an integrated and interdisciplinary research framework. In 2020, Prof. Ströbel co-initiated the "Cancer Scout" AI-related research project with Siemens, receiving a grant of €9.6 million from the German Federal Ministry of Education and Research (BMBF). This project aims to develop an AI-based "digital biopsy" tool that analyzes the histological images—the most common diagnostic resource—to predict key molecular changes in tumors, thereby guiding targeted therapy decisions without additional molecular testing. The project has established a large-scale, multi-center image-molecular database, which contains thousands of samples from solid tumor cases, including lung cancer and colorectal cancer. Through deep learning algorithms, it identifies subtle correlations between cellular morphology and molecular alterations. This technology promises to reduce diagnostic costs, improve efficiency, and provide more accessible precision medicine for nearly 500,000 new cancer patients in Germany each year. Prof. Ströbel shared that he first visited Wuhan, China as early as 1993 and has since maintained a keen interest in the development of China’s healthcare system. He is set to launch a comprehensive collaboration with a prominent university-affiliated hospital in Shenzhen and has showed great interest in the future cooperation with the team of Gloryren, which will offer fresh perspectives to see China.